SELE and chronic myelogenous leukemia, BCR-ABL1 positive: Non-adhesion to E-selectin led to an increased cell cycle in CML LSCs with a concomitant upregulation of the transcription factor SCL/TAL-1, which further negatively regulated CD44 expression and potentiated the effect of the combinatorial treatment76.